| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0071 |
0.8 |
| mRNA |
L-685458 |
CTRPv2 |
pan-cancer |
AAC |
-0.007 |
0.8 |
| mRNA |
birinapant |
CTRPv2 |
pan-cancer |
AAC |
0.007 |
0.9 |
| mRNA |
ISOX |
CTRPv2 |
pan-cancer |
AAC |
-0.0059 |
0.9 |
| mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.006 |
0.9 |
| mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.9 |
| mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
-0.0064 |
0.9 |
| mRNA |
KU-55933 |
CTRPv2 |
pan-cancer |
AAC |
-0.0062 |
0.9 |
| mRNA |
hyperforin |
CTRPv2 |
pan-cancer |
AAC |
0.0064 |
0.9 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0058 |
0.9 |